Precision Biosciences Inc. (DTIL) intrinsic value & 10-year financials
Precision Biosciences Inc. (DTIL) has a Graham intrinsic value of $34.54 per share. At $5.77 on Oct 17, 2026, the stock trades 83% below that value. Over the last 9 fiscal years revenue grew 17.8% a year to $34.3M, with an average return on invested capital of 16.5%.
- Graham intrinsic value
- $34.54
- Share price (Oct 17, 2026)
- $5.77
- Price vs Graham value
- 83% below
- Market cap
- $74.0M
- Revenue (FY2025)
- $34.3M
- Revenue growth (9-yr CAGR)
- 17.8%
- ROIC (10-yr avg)
- 16.5%
- Free cash flow (FY2025)
- -$65.9M
DTIL 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $34.3M | -$45.7M | -$3.56 | -$65.9M | -152.2% | 283.6% |
| FY2024 | $68.7M | $7.2M | $1.04 | -$58.7M | -38.1% | 46.2% |
| FY2023 | $48.7M | -$61.3M | -$15.96 | -$86.1M | -89.8% | 62.6% |
| FY2022 | $25.1M | -$111.6M | -$1.27 | -$49.1M | -399.9% | 147.8% |
| FY2021 | $115.5M | -$30.6M | -$0.52 | -$15.9M | -34.1% | 74.6% |
| FY2020 | $24.3M | -$109.0M | — | -$92.4M | -452.2% | 298.6% |
| FY2019 | $22.2M | -$92.9M | — | -$95.7M | -392.1% | -104.2% |
| FY2018 | $10.9M | -$46.0M | — | -$66.0M | -440.2% | -677.5% |
| FY2017 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
PRECISION BIOSCIENCES INC revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
PRECISION BIOSCIENCES INC has earned high returns on invested capital, averaging 56.2% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
PRECISION BIOSCIENCES INC capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, PRECISION BIOSCIENCES INC is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $34.54 per share.